![]() |
![]() |
(11) | Number of the document | C 2281831 |
(68) | Number of the document | 2281831 |
(21) | Application number for Supplementary Protection Certificate | PA 2018 012 |
(22) | Date of filing the application | 2018-09-20 |
(41) | Date of publication of the application | 2018-11-12 |
Date of publication of SPC | 2020-08-25 | |
(24) | Date of coming into effect of SPC | 2026-03-02 |
(71) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
(73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(93) | EU/1/18/1272/001-002, 2018-03-21 |
(94) | 2031-03-01 |
(95) | Varicella Zoster viruso (VZV) glikoproteinas E (gE) |
SPC granted |